title: [Cancers of the anus: 32 cases].
abstract: The purpose of this retrospective study about 32 anal carcinoma was to determine the epidemoilogy, to discuss the therapeutic indications. The mean age of patients was 56.42 years and the protologic antecedent was 14%. According to the clinical staging: 1 patient was T1, 2 T2, 19 T3, 10T4; 1 No, 2 Nx, 7 N1, 10 N2, 12 N3; 25 M x, 5 MO, 2 M1. The histologic classification of OMS found: 17 epidermoid carcinoma, 12 glandular carcinoma, 1 transitional cell carcinoma, and 1 non classify cancer. 14 radical resection and 3 local resection were realised, 8 patients had an exclusive radiotherapy: 2 curative radiotherapy and 6 palliative. The morbidity was 9.37% and dominated by perineal suppuration and the mortality was 3.12%. The adjunctive radiotherapy must be the first treatment of the anal cancer in our countries.
authors.affiliation: Institut du Cancer de Dakar Université Cheikh Anta Diop de Dakar, Sénégal.
authors.forename: A
authors.initials: A
authors.lastname: Dem
authors.forename: A A
authors.initials: AA
authors.lastname: Kasse
authors.forename: M
authors.initials: M
authors.lastname: Diop
authors.forename: P
authors.initials: P
authors.lastname: Toure
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology / Q000601:surgery; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001005:Anus Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery*; D002173:Cancer Care Facilities; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000601:surgery; D002295:Carcinoma, Transitional Cell / Q000453:epidemiology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012675:Senegal / Q000453:epidemiology; D017678:Sex Distribution; D015996:Survival Rate; D016896:Treatment Outcome